Not exact matches
Chemotherapy works by killing
cancer cells by
targeting fast - dividing
cells, and in most cases, kills off some healthy
cells along the way, including nerve
cells in the
brain.
His work indicates that this
cell surface marker could serve as a
target for a novel
brain cancer vaccine or T -
cell therapies engineered to recognize and kill tumors carrying that neoantigen.
The Zika virus can cross the blood -
brain barrier, and could
target cancer cells, sparing normal adult
brain tissue and opening a potential new way to attack the disease.
Nagoya University - led research team shows in mice the potential of a special immune
cell that
targets a key protein in tumor growth that helps stop
brain cancer.
Would all this carefully
targeted weaponry that destroys
cancer cells without inflicting collateral damage on normal tissue work on
cancers outside the
brain?
A molecule in
cells that shuts down the expression of genes might be a promising
target for new drugs designed to treat the most frequent and lethal form of
brain cancer, according to a new study by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — J
cancer, according to a new study by researchers at The Ohio State University Comprehensive
Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — J
Cancer Center — Arthur G. James
Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — J
Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James).
Importantly, the PLK4 inhibitor was able to cross the blood -
brain barrier, which means that the drug can
target cancer cells in the
brain even when taken orally, avoiding the need for injection into the spinal fluid.
«
Brain cancer cells are very good at evading the host immune system, because they do not express specific
targets that can be recognized by immune
cells,» said Liau, professor and vice chair of neurosurgery.
«Stem
cell - based therapy for
targeting skin - to -
brain cancer: Stem
cells loaded with oncolytic viruses show promising results in preclinical models for
targeting skin
cancer metastases in the
brain.»
Tagged therapeutic stem
cells (green) are
targeting breast
cancer metastases (red) in the
brain of a mouse model.
A research team led by Christine Brown, Ph.D., and a clinical team headed by Behnam Badie, M.D., has received a $ 12.8 million grant from the CIRM to fund a phase 1 chimeric antigen receptor (CAR) T
cell trial
targeting an aggressive
brain cancer called malignant glioma, which includes glioblastoma.
They also found that drugs that
target this newly identified
cancer pathway can prevent tumor growth, both in human
cancer cells and mice with a form of
brain cancer.
Current projects in the laboratory include: 1) functional screens of ubiquitin ligases to identify novel
cancer drug
targets; 2) defining the molecular regulation of breast
cancer metastasis to the
brain; and 3) understanding signaling pathways that influence the response of
cancer cells to chemotherapy.
There are now multiple immunotherapies
targeting clearance of alpha - synuclein from the
brain in early - stage clinical trials, and multiple trials underway or in the works on the next generation of
cell replacement therapies for dopaminergic neurons, including the TRANSEURO trial; the Summit4StemCell initiative, put together by Jeanne Loring — a researcher at The Scripps Research Institute who is exceptionally engaged with turning her research into therapies; a Japanese trial to be run by Jun Takahashi of Kyoto University in Japan (cf. here and here); and a trial centered at Memorial Sloan Kettering
Cancer Center headed by
cell biologist Lorenz Studer.
There is maybe a unique opportunity for
brain cancer in
targeting stem
cell pathways.
It is unlikely that one  therapeutic agent will be able to
target the
cancer stem
cells in for example all types
brain tumors.